The Middle East & Africa human leukocyte antigen (HLA) testing market is expected to grow from US$ 35.78 million in 2022 to US$ 52.59 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2022 to 2028.
Despite the development of novel technological approaches such as optimized chemotherapy regimens, targeted therapies, and radiotherapy, patients suffering from many diseases still present poor survival outcomes. Technological advancements in histocompatibility have systematically addressed the issues related to the specificity of lymphocyte cross-matching. Treating a wide range of malignant and nonmalignant diseases requires hematopoietic stem cell transplantation (HSCT) as the last therapeutic resort. The HLA testing approach can help determine if the class I and II antibodies lead to a cross-match. The information obtained from the application of such sensitive and specific technologies can be used to predict cross-match results for highly sensitized patients.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa human leukocyte antigen (HLA) testing market growth at a notable CAGR during the forecast period.
Exhibit: Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation
The Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Middle East & Africa human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa.
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned
THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. are among the major companies operating in the Middle East & Africa human leukocyte antigen (HLA) testing market.
At 6.6% CAGR, the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market is speculated to be worth US$ 52.59 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Middle East and Africa human leukocyte antigen (HLA) testing market was valued at US$ 35.78 million in 2022 and is expected to reach US$ 52.59 million by 2028, registering an annual growth rate of 6.6% from 2022 to 2028. Increasing plasma donation and organ transplants procedures and increasing applications of HLA testing for human leukocyte antigen (HLA) testing are the critical factors attributed to the market expansion.
Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.
On the contrary, increasing accuracy errors of Middle East and Africa human leukocyte antigen (HLA) testing market.
Based on product & services, based on product market is segmented into reagents & consumables, instruments, and software & services. The Reagents & consumables segment held 52.34% market share in 2022, amassing US$ 18.72 million. It is projected to garner US$ 28.11 million by 2028 to expand at 7.0% CAGR during 2022–2028.
Based on technology, the Middle East and Africa human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies sub segmented into PCR-based molecular assays, sequencing-based molecular assays and others. The molecular assay technologies, segment held 83.20% market share in 2022, amassing US$ 29.76 million. It is projected to garner US$ 44.21 million by 2028 to expand at 6.8% CAGR during 2022–2028.
Based on end user, the Middle East and Africa human leukocyte antigen (HLA) testing market is divided into independent reference laboratories, hospital and transplant centers, and others. The independent reference laboratories segment held 47.77%market share in 2022, amassing US$ 17.09 million. It is projected to garner US$ 24.89 million by 2028 to expand at 6.5% CAGR during 2022–2028.
Based on country, the Middle East and Africa human leukocyte antigen (HLA) testing market has been categorised into the Saudi Arabia, South Africa, UAE and Rest of Middle East and Africa. Our regional analysis states that Saudi Arabia captured 40.06% market share in 2022. It was assessed at US$ 14.33 million in 2022 and is likely to hit US$ 21.68 million by 2028, exhibiting a CAGR of 7.1% during the forecast period.
Key players dominating the Middle East and Africa human leukocyte antigen (HLA) testing market are THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. among others.
In April 2022, CareDx, Inc. announced the launch of a fully functional next generation sequencing (NGS) HLA typing service lab in Stockholm, Sweden to support companies in research and academic studies working on HLA applications in vaccine and drug development as well as disease association studies. In August 2022, BioReference Laboratories announced that it has acquired the Ariosa centralized prenatal testing business from Roche. Ariosa’s non-invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, has been performed in over 1.5 million patients. The acquisition of Ariosa will complement current NIPS offering.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – By Product and Services
1.3.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – By Technology
1.3.3 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – By End User
1.3.4 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – By country
2. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market –Analysis
6.1 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
7. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services
7.1 Overview
7.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology
8.1 Overview
8.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
8.2.1.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User
9.1 Overview
9.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by country
10.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
10.1.1 Overview
10.1.2 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.1.3.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.2 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.1.3 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.1.3.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.1.4 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.2 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.1 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.2 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.2.3 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.2.3.1 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.2.4 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.3 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.1 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.2 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.3.3 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.3.3.1 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.3.4 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.4 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.4.1 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.4.2 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.4.3 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.4.3.1 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.4.4 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
11. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 CareDx
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES.
Table 1. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 2. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 3. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 4. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 5. Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 6. Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 7. Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 8. Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 9. UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 10. UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 11. UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 12. UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 13. South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 14. South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 15. South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 16. South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 18. Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 19. Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 20. Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 21. Organic Developments in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
Table 22. Inorganic Developments in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
Table 23. Glossary of Terms, Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
LIST OF FIGURES.
Figure 1. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation
Figure 2. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Overview
Figure 3. Reagents And Consumables Held Largest Share of Product Segment in Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Middle East & Africa: PEST Analysis
Figure 6. Experts’ Opinion
Figure 7. HLA Testing Market: Impact Analysis of Drivers and Restraints
Figure 8. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
Figure 10. Reagents and Consumables: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. Instruments: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. Software and Services : Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
Figure 14. Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. PCR-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Sequencing-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Non-Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)
Figure 20. Independent Reference Laboratories: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hospital & Transplant Centers: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. Middle East & Africa Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
Figure 26. Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Growth Strategies in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market (%)
